Moderna
Update in progressMRNA (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryBiotechnology
Moderna, Inc. is a biotechnology company that develops messenger RNA medicines for use worldwide. Its vaccine portfolio includes COVID-19 vaccines and options for respiratory diseases, seasonal flu, and other pathogens, plus vaccines targeting latent infections and bacterial diseases. It pursues oncology and rare disease programs and collaborates with multiple partners. Founded in 2010, it is based in Cambridge, Massachusetts.
Company score
- Sentiment
- 2.31
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.05
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 2.06
- Governance
- 0.33
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.67
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 1.49
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!